EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of bone mineral-reducing medications with two-year complications following open reduction and internal fixation of ankle fractures: a propensity score-matched analysis

Keenan Horani, Jad Lawand iD, Nicholas Tsavaris, Amir Alsaidi, Joshua Wang, Abdullah Ghali iD, Verdinand Ruelos, John Hagedorn

European Journal of Orthopaedic Surgery & Traumatology · 2026

DOI: 10.1007/s00590-026-05009-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2026. Verfasst von Keenan Horani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch at Galveston, Galveston, USA. Hauptthemen laut MEDLINE: Fracture Fixation, Internal, Ankle Fractures, Open Fracture Reduction, Bone Density Conservation Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone mineral-reducing medications (BMRMs) are commonly prescribed, but their association with outcomes after ankle open reduction and internal fixation (ORIF) is unclear. We evaluated preoperative exposure to ten BMRM classes and two-year complications after ankle ORIF.

Methods

Adults undergoing ankle ORIF at least two years before data extraction were identified in TriNetX. Exposure required at least one medication record 1–180 days before surgery for proton pump inhibitors (PPIs), glucocorticoids, loop diuretics, thiazolidinediones, calcineurin inhibitors, aromatase inhibitors, selective serotonin reuptake inhibitors (SSRIs), first- or second-generation antipsychotics, or antiepileptics. Exposed patients were 1:1 propensity score matched to patients unexposed to all classes. Risk ratios (RRs) for five two-year outcomes were adjusted for false discovery rate (FDR).

Results

Matched cohorts included 227–9,858 patients per group. Nonunion was more frequent with glucocorticoids (2.36% vs. 1.72%; RR 1.37), PPIs (2.68% vs. 1.79%; RR 1.50), loop diuretics (3.98% vs. 2.20%; RR 1.81), SSRIs (2.49% vs. 1.72%; RR 1.45) and antiepileptics (2.70% vs. 1.73%; RR 1.56); all 95% confidence intervals excluded 1 and all FDR q ≤ 0.023. Antiepileptics were also associated with revision ORIF, the primary outcome (3.55% vs. 2.65%; RR 1.34, 95% CI 1.13–1.59; q = 0.009). No class was associated with device infection or hardware failure. Outcomes for thiazolidinediones, calcineurin inhibitors and aromatase inhibitors were not estimable (too few events).

Conclusion

Preoperative glucocorticoid, PPI, loop diuretic, SSRI or antiepileptic exposure was associated with higher two-year nonunion risk after ankle ORIF, and antiepileptic exposure with revision. These hypothesis-generating associations may reflect confounding by indication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fracture Fixation, InternalAnkle FracturesOpen Fracture ReductionBone Density Conservation AgentsPostoperative ComplicationsFractures, UnunitedHumansFemaleMaleMiddle AgedPropensity ScoreAdultProton Pump InhibitorsRetrospective StudiesAgedGlucocorticoidsSelective Serotonin Reuptake InhibitorsAnticonvulsants

Stichwörter der Autor:innen

Ankle FractureBone-mineral reducing medicationsNonunionOpen fracture reduction

Substanzen

Bone Density Conservation AgentsProton Pump InhibitorsGlucocorticoidsSelective Serotonin Reuptake InhibitorsAnticonvulsants

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch at Galveston, Galveston, USA.
  • Medical College of Georgia, University of Georgia, Augusta, Georgia.
  • Joseph Bankart Department of Orthopedic Surgery, Baylor College of Medicine, Houston, USA.
  • Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch at Galveston, Galveston, USA. joswang@utmb.edu.

ORCID-Profile: Jad Lawand, Abdullah Ghali

Zitieren

APA

Horani, K., Lawand, J., Tsavaris, N., Alsaidi, A., Wang, J., Ghali, A., Ruelos, V., & Hagedorn, J. (2026). Association of bone mineral-reducing medications with two-year complications following open reduction and internal fixation of ankle fractures: a propensity score-matched analysis. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-026-05009-0

Vancouver

Horani K, Lawand J, Tsavaris N, Alsaidi A, Wang J, Ghali A, et al. Association of bone mineral-reducing medications with two-year complications following open reduction and internal fixation of ankle fractures: a propensity score-matched analysis. European Journal of Orthopaedic Surgery & Traumatology. 2026. doi:10.1007/s00590-026-05009-0

BibTeX
@article{Horani2026,
  author = {Horani, Keenan and Lawand, Jad and Tsavaris, Nicholas and Alsaidi, Amir and Wang, Joshua and Ghali, Abdullah and Ruelos, Verdinand and Hagedorn, John},
  title = {Association of bone mineral-reducing medications with two-year complications following open reduction and internal fixation of ankle fractures: a propensity score-matched analysis},
  journal = {European Journal of Orthopaedic Surgery & Traumatology},
  year = {2026},
  doi = {10.1007/s00590-026-05009-0}
}
Kostenlos starten →